Hepatitis B Drug Relaunch
As AOR, we repositioned and strategized ways to target various HCP groups who treat Hepatitis B. The drug is indicated for post exposure prophylaxis (PEP) of the Hepatitis B virus (HBV) for individuals exposed to through household, needle stick, perinatal and sexual exposure. We utilized brand campaigns, digital campaigns, CRM programs, KOL development, live events, and print marketing to educate and promote the brand that treats PEP of the Hepatitis B virus (HBV).
Biotest Pharmaceuticals Corporation, Nabi-HB®
Advisory board, branding, campaign, digital and print promotion, educational materials, key messages, program identity